We're pretty excited!» Read More
CNBC's Andrea Day reports on more than $200 million fraud that involved a number of doctors and a blood lab in New Jersey.
CNBC's Brian Sullivan reports on graywater as a way to help people reuse water in their home. The process costs about $2,500 for installation.
After years of drought, California is preparing for wildfire season, with CNBC's Brian Sullivan.
Here's the airline stocks you should watch today, with CNBC's Phil LeBeau.
Vertical farming is traditionally done inside with artificial light, but one farm is taking the idea outside, reports CNBC's Brian Sullivan.
California is the nation's largest farm state, and the almond industry is making some people nuts for its huge water usage, reports CNBC's Jane Wells.
Which stocks to buy in a stock-picker's market
After being battered by falling crude prices, many U.S. energy stocks may soon blow past broader U.S. markets, one analyst said.
Tesla is making progress on the home battery front, said Colin Langan, auto analyst at UBS, in an interview with CNBC on Wednesday.
Convergex's Nicholas Colas explains why investors should reduce exposure to large caps in favor of small- and mid-cap stocks.
CNBC's Brian Sullivan sits down with Richard Kinder, Kinder Morgan CEO, for an exclusive interview to discuss potential acquisitions and big oil opportunities.
Larry McDonald, Societe Generale, and Erin Gibbs, S&P Capital IQ, discusses value in the energy sector and determine whether energy is a yield trade.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Amazon, Mylan, and Depomed.
Iraq takes back ground from ISIS in Ramadi; Israel remembers fallen soldiers; and powerful storms pound Australia, reports CNBC's Sue Herera.
Colin Langan, UBS auto analyst, joins CNBC's Phil LeBeau to discuss Tesla, the auto industry and what consumers want in cars.
Daniel Huang of Wall Street Journal wrote an article on how a growing number of retail traders are using social media to gain "investing fame." CNBC contributor Herb Greenberg, weighs in.
Corey Davis, Canaccord Genuity, discusses big deals in pharmaceutical including Teva's bid for Mylan.
CNBC's Meg Tirrell reports on Abbott Laboratories' earnings and deals associated with this company.
Lloyd Byrne of Nomura and head of North American E&P research, gives perspective on his energy bets.